Ultragenyx Pharmaceutical
RARE
#4547
Rank
HK$16.50 B
Marketcap
HK$170.85
Share price
2.25%
Change (1 day)
-44.55%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: HK$16.50 Billion

As of March 2026 Ultragenyx Pharmaceutical has a market cap of HK$16.50 Billion. This makes Ultragenyx Pharmaceutical the world's 4547th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$16.50 B-35.67%
2025HK$25.66 B-17.55%
2024HK$31.12 B1.5%
2023HK$30.66 B20.85%
2022HK$25.37 B-43.22%
2021HK$44.69 B-37.05%
2020HK$70.99 B269.02%
2019HK$19.23 B11.09%
2018HK$17.31 B12.21%
2017HK$15.43 B-30.73%
2016HK$22.27 B-34.1%
2015HK$33.80 B211.04%
2014HK$10.86 B

End of Day market cap according to different sources

On Mar 16th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

HK$16.50 Billion
by Nasdaq info icon info icon
HK$16.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
HK$5.34 B-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$5.03 B-69.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.33 B 114.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$86.48 B 423.85%๐Ÿ‡บ๐Ÿ‡ธ USA